Arkolith/Insider Trading/ELVN/Form 4

Orbimed Advisors LLC

10% OwnerEnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$12.7M
Net Open-Market Flow
-$12.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)9K$45.02$409K246K
Jun 15, 2026Sell(S)272K$45.02$12.3M7.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000637) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML